세계의 의약품 Fill Finish 아웃소싱 시장 보고서(2025년)

Pharmaceutical fill and finish outsourcing involves the practice of contracting with specialized pharmaceutical manufacturing companies to provide services related to pharmaceutical filling and sealing operations into end-use containers with the required sterility and accuracy. This outsourcing is employed by pharmaceutical and biopharmaceutical companies to leverage specialized expertise, avoid the high costs associated with acquiring automated equipment, meet stringent regulatory agency standards, enhance efficiency, and gain flexibility in terms of production capacity.

The primary types of pharmaceutical fill and finish outsourcing products are liquids, solids, and semi-solids. Liquids refer to pharmaceutical formulations that are pourable and consist of a combination of active drug or chemical components and inert components. These formulations may be processed from organic substances isolated from animal origin, organic substances isolated from microorganisms, and inorganic substances. Pharmaceutical and biopharmaceutical companies commonly utilize these outsourcing services for their production needs.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The pharmaceutical fill and finish outsourcing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical fill and finish outsourcing market statistics, including pharmaceutical fill and finish outsourcing industry global market size, regional shares, competitors with a pharmaceutical fill and finish outsourcing market share, detailed pharmaceutical fill and finish outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical fill and finish outsourcing industry. This pharmaceutical fill-and-finish outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical fill and finish outsourcing market size has grown strongly in recent years. It will grow from $3.53 billion in 2024 to $3.77 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to the emergence of contract development and manufacturing organizations (CDMOs, demand for specialized services, shift to outsourced models, market expansion strategies, and stringent regulatory requirements.

The pharmaceutical fill and finish outsourcing market size is expected to see strong growth in the next few years. It will grow to $5.25 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to demand for specialized services, global market expansion, focus on core competencies, rapid market entry for new drugs, flexibility in manufacturing capacity, anticipated need for flexible manufacturing capacity to accommodate fluctuation. Major trends in the forecast period include increased biologics outsourcing, sustainability initiatives, geographic expansion of outsourcing hubs, technological integration for efficiency, rise in contract development and manufacturing organizations (CDMOs).

The forecast of 8.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. drug manufacturing by inflating prices of sterile vial-filling machines and lyophilization equipment developed in Italy and China, resulting in production bottlenecks and higher biologic drug costs for patients. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing demand for biologic drugs is anticipated to drive the growth of the pharmaceutical fill and finish outsourcing market in the future. Biologic drugs, often referred to as biologics or biosimilars, are a category of pharmaceutical products derived from living organisms or containing components sourced from living organisms. By outsourcing the fill and finish phase of production, drug manufacturers can leverage the expertise and infrastructure of contract manufacturing organizations (CMOs). This enables pharmaceutical companies to concentrate on the development, research, and scaling of their biologic drugs while relying on CMOs for efficient and cost-effective fill and finish operations. For example, in September 2023, the Association for Accessible Medicines (AAM), a US-based trade association for manufacturers of generic prescription drugs and pharmaceutical chemicals, reported that in 2022, annual savings from biosimilar drugs exceeded $408 billion, reflecting a $35 billion increase compared to 2021. This trend indicates a consistent annual growth rate of 7-10 percent in savings in recent years. Therefore, the rising demand for biologic drugs is expected to boost the pharmaceutical fill and finish outsourcing market.

The rise in investments in biopharmaceutical research and development (R&D) is significantly fueling the growth of the pharmaceutical fill and finish outsourcing market. R&D investments refer to the financial resources allocated to activities aimed at discovering, developing, and eventually bringing new biopharmaceutical products to market. With a strong emphasis on innovation and drug development, pharmaceutical companies may increase their allocation of resources to research and development. Outsourcing fill and finish services allows these companies to redirect resources and investments toward core R&D activities. For instance, in January 2023, Roche Holding AG, a biopharmaceutical manufacturer based in Switzerland, announced a 3.7% increase in its R&D expenditure for 2022 compared to 2021. Consequently, the heightened investments in research and development by biopharmaceutical companies are driving the pharmaceutical fill and finish outsourcing market.

Product innovations represent a significant trend gaining traction in the pharmaceutical fill and finish outsourcing market. Companies within this sector are actively developing new and innovative products to maintain their competitive edge. For example, in January 2024, Stevanato Group, an Italy-based provider of drug containment and delivery solutions for the pharmaceutical and life sciences industries, introduced the EZ-fill Kit and a laboratory fill and finish service. The EZ-fill Kit is designed to streamline the filling process for small batches of injectable drugs, making it particularly beneficial during clinical trials and early commercial phases. This innovation helps pharmaceutical companies enhance small batch production, reduce costs, and accelerate time-to-market. Furthermore, the new non-GMP laboratory fill and finish service facilitates early evaluation of how the fill-and-finish process affects product performance. These innovations aim to improve efficiency and uphold high standards in drug development and production.

Leading companies in the pharmaceutical fill and finish outsourcing market are prioritizing the development of sustainable packaging materials and methods to reduce their carbon footprint and promote environmental conservation. Sustainable packaging involves creating and utilizing packaging that minimizes its environmental impact throughout its entire lifecycle. For instance, in November 2023, Amcor, an Australia-based pharmaceutical packaging company, launched next-generation HealthCare Recycle-Ready Medical Laminates. Amcor is producing all-film packaging that meets device application performance requirements while decreasing the overall carbon footprint of the final package and ensuring recyclability in the polyethylene stream. This solution features a polyethylene (PE) laminate that is a monomaterial suitable for various packaging formats, enabling it to replace non-recyclable lidding for 3D thermoformed packages with recyclable lidding for products such as drapes, protective materials, catheters, injection systems, and tubing systems.

In January 2023, AstraZeneca Pharmaceuticals LP, a US-based biopharmaceutical company, completed the acquisition of CinCor Pharma Inc. for $1.8 billion. This strategic move allows AstraZeneca to strengthen its cardiorenal portfolio by incorporating CinCor's promising compound, baxdrostat (CIN-107). Baxdrostat, an aldosterone synthase inhibitor (ASI), is designed to lower blood pressure in patients with treatment-resistant hypertension, including those with chronic kidney disease. CinCor Pharma Inc. is a US-based clinical-stage biopharmaceutical company specializing in kidney disease medications and treatments.

Major companies operating in the pharmaceutical fill and finish outsourcing market include Groninger and Co. GmbH, Merck and Co.Inc., Abbott Laboratories, Wockhardt Limited., Boehringer Ingelheim International GmbH, Becton Dickinson and Company, AbbVie Inc., Teva Pharmaceuticals Industries Ltd., Recipharm AB., Lonza Group AG, Catalent Inc., Dr. Reddys Laboratories Ltd., West Pharmaceutical Services Inc., Sun Pharmaceutical Industries Ltd., Patheon N.V., Piramal Enterprises Ltd., Gerresheimer AG, CordenPharma International, Fujifilm Diosynth Biotechnologies, Optima Packaging Group GmbH, Jubilant HollisterStier LLC., Ajinomoto Bio-Pharma Services, Cytovance Biologics Inc., Grand River Aseptic Manufacturing, Baxter Pharmaceutical Solutions LLC., Halo Pharma Inc., MabPlex Inc., August Bioservices

North America was the largest region in the pharmaceutical fill and finish outsourcing market in 2024. The regions covered in the pharmaceutical fill and finish outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical fill and finish outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical fill and finish outsourcing market includes revenues earned by entities by providing outsourcing of aseptic or sterile filling and finishing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Fill and Finish Outsourcing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical fill and finish outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical fill and finish outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical fill and finish outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By State Of Finished Products: Liquid, Solids, Semi Solids
• 2) By Content: Organic Substances Isolated From Animal Origin, Organic Substances Isolated From Microorganisms, Inorganic Substances
• 3) By End-Users: Biopharmaceutical Companies, Pharmaceutical Companies
• Subsegments:
• 1) By Liquid: Injectables Solutions Suspensions
• 2) By Solids: Tablets Capsules Powders
• 3) By Semi-Solids: Ointments Creams Gels
• Companies Mentioned: Groninger and Co. GmbH; Merck and Co.Inc.; Abbott Laboratories; Wockhardt Limited.; Boehringer Ingelheim International GmbH; Becton Dickinson and Company; AbbVie Inc.; Teva Pharmaceuticals Industries Ltd.; Recipharm AB.; Lonza Group AG; Catalent Inc.; Dr. Reddys Laboratories Ltd.; West Pharmaceutical Services Inc.; Sun Pharmaceutical Industries Ltd.; Patheon N.V.; Piramal Enterprises Ltd.; Gerresheimer AG; CordenPharma International; Fujifilm Diosynth Biotechnologies; Optima Packaging Group GmbH; Jubilant HollisterStier LLC.; Ajinomoto Bio-Pharma Services; Cytovance Biologics Inc.; Grand River Aseptic Manufacturing; Baxter Pharmaceutical Solutions LLC.; Halo Pharma Inc.; MabPlex Inc.; August Bioservices
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Fill and Finish Outsourcing Market Characteristics

3. Pharmaceutical Fill and Finish Outsourcing Market Trends And Strategies

4. Pharmaceutical Fill and Finish Outsourcing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pharmaceutical Fill and Finish Outsourcing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharmaceutical Fill and Finish Outsourcing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharmaceutical Fill and Finish Outsourcing Market Growth Rate Analysis
• 5.4. Global Pharmaceutical Fill and Finish Outsourcing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharmaceutical Fill and Finish Outsourcing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharmaceutical Fill and Finish Outsourcing Total Addressable Market (TAM)

6. Pharmaceutical Fill and Finish Outsourcing Market Segmentation

• 6.1. Global Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid
• Solids
• Semi Solids
• 6.2. Global Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Organic Substances Isolated From Animal Origin
• Organic Substances Isolated From Microorganisms
• Inorganic Substances
• 6.3. Global Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biopharmaceutical Companies
• Pharmaceutical Companies
• 6.4. Global Pharmaceutical Fill and Finish Outsourcing Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectables Solutions Suspensions
• 6.5. Global Pharmaceutical Fill and Finish Outsourcing Market, Sub-Segmentation Of Solids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets Capsules Powders
• 6.6. Global Pharmaceutical Fill and Finish Outsourcing Market, Sub-Segmentation Of Semi-Solids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ointments Creams Gels

7. Pharmaceutical Fill and Finish Outsourcing Market Regional And Country Analysis

• 7.1. Global Pharmaceutical Fill and Finish Outsourcing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharmaceutical Fill and Finish Outsourcing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Fill and Finish Outsourcing Market

• 8.1. Asia-Pacific Pharmaceutical Fill and Finish Outsourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Fill and Finish Outsourcing Market

• 9.1. China Pharmaceutical Fill and Finish Outsourcing Market Overview
• 9.2. China Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Fill and Finish Outsourcing Market

• 10.1. India Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Fill and Finish Outsourcing Market

• 11.1. Japan Pharmaceutical Fill and Finish Outsourcing Market Overview
• 11.2. Japan Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Fill and Finish Outsourcing Market

• 12.1. Australia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Fill and Finish Outsourcing Market

• 13.1. Indonesia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Fill and Finish Outsourcing Market

• 14.1. South Korea Pharmaceutical Fill and Finish Outsourcing Market Overview
• 14.2. South Korea Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Fill and Finish Outsourcing Market

• 15.1. Western Europe Pharmaceutical Fill and Finish Outsourcing Market Overview
• 15.2. Western Europe Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Fill and Finish Outsourcing Market

• 16.1. UK Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Fill and Finish Outsourcing Market

• 17.1. Germany Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Fill and Finish Outsourcing Market

• 18.1. France Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Fill and Finish Outsourcing Market

• 19.1. Italy Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Fill and Finish Outsourcing Market

• 20.1. Spain Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Fill and Finish Outsourcing Market

• 21.1. Eastern Europe Pharmaceutical Fill and Finish Outsourcing Market Overview
• 21.2. Eastern Europe Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Fill and Finish Outsourcing Market

• 22.1. Russia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Fill and Finish Outsourcing Market

• 23.1. North America Pharmaceutical Fill and Finish Outsourcing Market Overview
• 23.2. North America Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Fill and Finish Outsourcing Market

• 24.1. USA Pharmaceutical Fill and Finish Outsourcing Market Overview
• 24.2. USA Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Fill and Finish Outsourcing Market

• 25.1. Canada Pharmaceutical Fill and Finish Outsourcing Market Overview
• 25.2. Canada Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Fill and Finish Outsourcing Market

• 26.1. South America Pharmaceutical Fill and Finish Outsourcing Market Overview
• 26.2. South America Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Fill and Finish Outsourcing Market

• 27.1. Brazil Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Fill and Finish Outsourcing Market

• 28.1. Middle East Pharmaceutical Fill and Finish Outsourcing Market Overview
• 28.2. Middle East Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Fill and Finish Outsourcing Market

• 29.1. Africa Pharmaceutical Fill and Finish Outsourcing Market Overview
• 29.2. Africa Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Fill and Finish Outsourcing Market Competitive Landscape And Company Profiles

• 30.1. Pharmaceutical Fill and Finish Outsourcing Market Competitive Landscape
• 30.2. Pharmaceutical Fill and Finish Outsourcing Market Company Profiles
  • 30.2.1. Groninger and Co. GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck and Co.Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Wockhardt Limited. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Fill and Finish Outsourcing Market Other Major And Innovative Companies

• 31.1. Becton Dickinson and Company
• 31.2. AbbVie Inc.
• 31.3. Teva Pharmaceuticals Industries Ltd.
• 31.4. Recipharm AB.
• 31.5. Lonza Group AG
• 31.6. Catalent Inc.
• 31.7. Dr. Reddys Laboratories Ltd.
• 31.8. West Pharmaceutical Services Inc.
• 31.9. Sun Pharmaceutical Industries Ltd.
• 31.10. Patheon N.V.
• 31.11. Piramal Enterprises Ltd.
• 31.12. Gerresheimer AG
• 31.13. CordenPharma International
• 31.14. Fujifilm Diosynth Biotechnologies
• 31.15. Optima Packaging Group GmbH

32. Global Pharmaceutical Fill and Finish Outsourcing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Fill and Finish Outsourcing Market

34. Recent Developments In The Pharmaceutical Fill and Finish Outsourcing Market

35. Pharmaceutical Fill and Finish Outsourcing Market High Potential Countries, Segments and Strategies

• 35.1 Pharmaceutical Fill and Finish Outsourcing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharmaceutical Fill and Finish Outsourcing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharmaceutical Fill and Finish Outsourcing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer